XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Commitments and Contingencies (Details Narrative) - USD ($)
3 Months Ended
Jan. 09, 2023
Jan. 06, 2023
Jan. 04, 2023
Dec. 30, 2022
Mar. 31, 2023
Subsidiary, Sale of Stock [Line Items]          
Issuance of ordinary shares through public offering, shares       5,800  
Payments for underwriting expense     $ 1,500,000    
Number of stock exercisable, shares     115,500    
Share issued price per share $ 10.18   $ 2.00    
Option description       The option and the 58,000 Units, as well as the 58,000 ordinary shares, the warrants to purchase 58,000 ordinary shares that may be issued upon exercise of the option and the rights to purchase 5,800 ordinary shares upon the completion of an initial business combination, have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the commencement of sales in our IPO pursuant to Rule 5110(e)(1) of FINRA’s Rules, during which time the option may not be sold, transferred, assigned, pledged or hypothecated, or be subject of any hedging, short sale, derivative or put or call transaction that would result in the economic disposition of the securities, except as permitted under FINRA Rule 5110(e)(2). The Company determined fair value of the Unit Purchase Option issued to the underwriters and recorded an amount to additional paid-in capital, net of purchased cost, in the balance sheets on the day of the IPO which is the grant date.  
Number of units option exercised, shares       $ 58,000  
Warrants to purchase common shares       58,000  
Common Stock [Member]          
Subsidiary, Sale of Stock [Line Items]          
Issuance of ordinary shares through public offering, shares       58,000 6,000,000
Over-Allotment Option [Member]          
Subsidiary, Sale of Stock [Line Items]          
Issuance of ordinary shares through public offering, shares 900,000 900,000 900,000    
Sale of price per share $ 10.00 $ 10.00      
Payments for underwriting expense $ 112,500        
Share price     $ 0.35    
Deferred underwriting commission     $ 2,415,000    
Number of stock exercisable, shares   900,000      
Unit Purchase Option [Member]          
Subsidiary, Sale of Stock [Line Items]          
Sale of price per share       $ 100  
Number of stock exercisable, shares       58,000  
Share issued price per share       $ 11.50  
Percentage of market value       115.00%